Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
Abstract
Extracellular matrix (ECM) stiffening with downstream activation of mechanosensitive pathways is strongly implicated in fibrosis. We previously reported that altered collagen nanoarchitecture is a key determinant of pathogenetic ECM structure-function in human fibrosis (Jones et al., 2018). Here, through human tissue, bioinformatic and ex vivo studies we provide evidence that hypoxia-inducible factor (HIF) pathway activation is a critical pathway for this process regardless of the oxygen status (pseudohypoxia). Whilst TGFβ increased the rate of fibrillar collagen synthesis, HIF pathway activation was required to dysregulate post-translational modification of fibrillar collagen, promoting pyridinoline cross-linking, altering collagen nanostructure, and increasing tissue stiffness. In vitro, knockdown of Factor Inhibiting HIF (FIH), which modulates HIF activity, or oxidative stress caused pseudohypoxic HIF activation in the normal fibroblasts. By contrast, endogenous FIH activity was reduced in fibroblasts from patients with lung fibrosis in association with significantly increased normoxic HIF pathway activation. In human lung fibrosis tissue, HIF-mediated signalling was increased at sites of active fibrogenesis whilst subpopulations of human lung fibrosis mesenchymal cells had increases in both HIF and oxidative stress scores. Our data demonstrate that oxidative stress can drive pseudohypoxic HIF pathway activation which is a critical regulator of pathogenetic collagen structure-function in fibrosis.
Editor's evaluation
The reviewers found your manuscript of broad interest to researchers interested in lung biology, as the study builds upon the previous original work of the authors, by identifying a pathway that regulates collagen nanostructure and stiffness in lung fibrosis and demonstrating that this pathway it is independent of pathways regulating collagen synthesis. They also valued the elegant analysis you performed to validate the specificity of experimental finding, and demonstrate that HIF activation is required for the increased tissue stiffness associated with fibrosis.
https://doi.org/10.7554/eLife.69348.sa0Introduction
We previously identified that in the lung tissue of patients with idiopathic pulmonary fibrosis (IPF) there is increased pyridinoline collagen cross-linking and altered collagen fibril nano-architecture, with individual collagen fibrils being structurally and functionally abnormal (Jones et al., 2018). This was associated with increased tissue expression of lysyl hydroxylase 2 (LH2/PLOD2, which catalyses telopeptide lysine hydroxylation to determine pyridinoline cross-linking) and the lysyl oxidase-like (LOXL) enzymes LOXL2 and LOXL3, which initiate covalent collagen cross-linking (Jones et al., 2018). This pyridinoline cross-linking, rather than any change in collagen deposition per se, determined increased IPF tissue stiffness. Inhibiting pyridinoline cross-linking normalised mechano-homeostasis and limited the self-sustaining effects of ECM on fibrosis progression. Whilst identifying the importance of altered collagen nanoarchitecture to human lung fibrosis pathogenesis, the upstream mechanisms that dysregulate collagen structure-function to promote progressive fibrosis rather than tissue repair were not determined. Here, we investigated possible mechanisms and established their relevance to human lung fibrosis.
Results
The pyridinoline collagen fibrillogenesis genes PLOD2 and LOXL2 are co-expressed at sites of active fibrogenesis
In our previous work comparing human IPF lung tissue with age-matched control lung tissue, we identified that in bulk IPF lung tissue lysates there are significant increases in the relative expression levels of the collagen modifying enzymes LOXL2, LOXL3, and LOXL4, as well as PLOD2 (also known as lysyl hydroxylase or LH2) (Jones et al., 2018). To further investigate this observation, we first studied the transcriptomic profiles of fibroblast foci, the sites of active fibrogenesis in IPF. We analysed a data set we recently generated by integrating laser-capture-microdissection and RNA-Seq (LCMD/RNA-seq) which enabled profiling of the in situ transcriptome of fibroblast foci as well as alveolar septae from control tissue and IPF tissue (Gene Expression Omnibus (GEO) GSE169500). The LOXL enzyme with the greatest expression in fibroblast foci was LOXL2 (Figure 1a–e). Whilst LOXL3 and LOXL4 expression was increased within fibroblast foci, only limited expression was identified (Figure 1d and e). Furthermore, PLOD2 expression was significantly increased within fibroblast foci (Figure 1f), and PLOD2 expression levels correlated (r = 0.63, P = 0.04) with those of LOXL2 (Figure 1g) but not with those of other LOXL enzymes (Figure 1—figure supplement 1a-d), suggesting possible co-ordinated regulation of PLOD2 and LOXL2 gene expression. By contrast, expression of the major collagen fibrillogenesis gene COL1A1 did not significantly correlate with their expression (Figure 1—figure supplement 1e), suggesting that, in lung fibrosis, distinct pathways might promote pyridinoline cross-linking to dysregulate collagen fibril nano-structure independently of pathways regulating major fibrillar collagen synthesis. We then performed RNA in situ hybridisation upon IPF lung tissue, with semi-quantitative analysis (Supplementary file 1a); the results showed that the greatest expression of LOXL2 and PLOD2 in IPF tissue was by mesenchymal cells within fibroblast foci, and that LOXL2 and PLOD2 are co-expressed within the same cells (Figure 1h) within areas of fibrillar collagen deposition (Figure 1—figure supplement 1f-h).
HIF pathway activation is a key inducer of PLOD2 and LOXL2 expression in lung fibroblasts
To investigate common regulators of PLOD2 and LOXL2 in lung fibrosis, we studied their expression in primary human lung fibroblasts over a 72-hr time course following activation (Figure 2—figure supplement 1a) of transforming growth factor beta (TGFβ), epidermal growth factor (EGF), hypoxia inducible factors (HIF) or Wnt signalling pathways, each of which have been implicated in fibrogenesis (Richeldi et al., 2017; Yao et al., 2019; Martin-Medina et al., 2018; Königshoff et al., 2008; Yue et al., 2010; Bodempudi et al., 2014; Hill et al., 2019a; Yao et al., 2021; Zhou et al., 2021). A prodrug form of the hypoxia mimetic and broad spectrum 2-oxoglutarate oxygenase inhibitor N-oxalylglycine (dimethyloxalylglycine, DMOG) (Chowdhury et al., 2013), which inhibits the HIF prolyl hydroxylases with consequent stabilisation of HIF1α and HIF2α, most strongly upregulated both PLOD2 and LOXL2 mRNA and protein levels (Figure 2a–c and Figure 2—figure supplement 1b) but did not induce expression of interstitial collagen genes (COL1A1, COL3A1) (Figure 2d and Figure 2—figure supplement 1c). In contrast, TGFβ1 strongly induced COL1A1 and COL3A1 and this was associated with smaller up-regulation of PLOD2 at 24 hr and of LOXL2 at 72 hr (Figure 2a–d; Figure 2—figure supplement 1c). No induction of PLOD2 or LOXL2 was identified with canonical Wnt (Wnt3a), non-canonical Wnt (Wnt5a) or EGF pathway activation (Figure 2a–c). We further extended these observations by showing that treatment with the selective HIF prolyl 2 hydroxylase inhibitor, N-[[1,2-dihydro-4-hydroxy-2-oxo-1-(phenylmethyl)–3-quinolinyl]carbonyl]-glycine (IOX2) (Chowdhury et al., 2013) or culture for 24 hr under hypoxic conditions induced expression of PLOD2 and LOXL2 (Figure 2—figure supplement 1d, e), with immunofluorescent staining confirming an increase in intracellular LOXL2 and PLOD2 expression following DMOG or IOX2 treatment in comparison to treatment with TGFβ1 (Figure 2e). Transcriptional activation of HIF pathways requires assembly of a heterodimer between HIF1α or HIF2α and their obligate binding partner HIF1β (Schödel and Ratcliffe, 2019; Schofield and Ratcliffe, 2004). To confirm the dependence of the induction of PLOD2 and LOXL2 expression upon HIF levels, siRNA knockdown against HIF1α(HIF1A), HIF2α(EPAS1), and HIF1β (ARNT) was performed (Figure 3a). The knockdown of HIF1α, but not HIF2α prevented DMOG induction of PLOD2 mRNA and protein expression, whilst LOXL2 required silencing of both HIF1α and HIF2α or HIF1β (Figure 3b–d). Together, these findings identify that HIF stabilisation is required to orchestrate induction of PLOD2 and LOXL2 expression in human lung fibroblasts.
HIF pathway activation and TGFβ1 synergistically increase PLOD2 expression
Given that TGFβ1 strongly induced major collagen fibrillogenesis genes whilst HIF pathways most strongly increased PLOD2 and LOXL2 expression levels, we investigated the effects of activating these pathways individually or in combination using lung fibroblasts from patients with IPF. The effect of DMOG in the absence or presence of TGFβ1 upon PLOD2 and LOXL2 induction (Figure 4a–c) was comparable to that identified using normal control lung fibroblasts. When combined, a synergistic effect upon the induction of PLOD2 expression was apparent which was greater than either pathway alone (Figure 4a and c). Whilst expression of LOXL2 was also increased with the combination of HIF stabilisation and TGFβ1, a corresponding increase in LOXL2 protein levels within cell lysates was not apparent. As LOXL2 is processed intracellularly before being extracellularly secreted, we therefore investigated whether increased secretion of LOXL2 was occurring; this identified that under conditions with HIF stabilisation LOXL2 secretion was increased in both IPF fibroblasts (Figure 4d) and control fibroblasts (Figure 4—figure supplement 1).
Although TGFβ1 alone was sufficient to induce interstitial collagen gene (COL1A1) expression (Figure 4—figure supplement 2), HIF stabilisation significantly increased the ratio of PLOD2 and LOXL2 gene expression relative to fibrillar collagen (COL1A1) gene expression while TGFβ1 did not (Figure 4e and f), suggesting that TGFβ activity alone may be insufficient to promote the altered collagen cross-linking that is present in IPF lung tissue. Together these findings demonstrate that whilst TGFβ1 has a dominant role in increasing the rate of synthesis of major fibrillar collagens, HIF pathways may have a key role in regulating pathological post-translational modifications and collagen structure in lung fibrosis.
HIF pathway activation alters collagen structure-function and increases tissue stiffness
To investigate whether HIF pathway activation acts as a mechanism that drives pathologic collagen crosslinking by disproportionate induction of collagen-modifying enzymes relative to TGFβ-induced collagen fibril synthesis, we employed our long-term (6 weeks) 3D in vitro model of lung fibrosis using primary human lung fibroblasts from patients with IPF, which we have previously described (Jones et al., 2018) and which allows direct evaluation of pyridinoline cross-linking, collagen nanostructure, and tissue biomechanics. We employed the selective HIF-prolyl hydroxylase inhibitor IOX2 to test within the in vitro fibrosis model, confirming HIF stabilisation by IOX2 following 2-week culture, and that in combination with TGFβ1 this promoted PLOD2 and LOXL2 expression (Figure 5—figure supplement 1a and b). Following 6 weeks of culture with TGFβ1 in the absence (control) or presence of IOX2 to drive HIF pathway activation, mature pyridinoline cross links (DPD/PYD) were significantly increased by the addition of IOX2 (Figure 5a) and these achieved a level comparable to our previous findings in IPF tissue (Jones et al., 2018). The biomechanical consequence of HIF stabilisation by IOX2 treatment was then investigated with parallel plate compression testing, identifying a greater than threefold increase in tissue stiffness by the addition of IOX2 (Figure 5b), with the mean (± SEM) compressive modulus measurement following IOX2 treatment of (107.1 ± 10.7) kPa comparable to the maximal stiffness of between 50 and 150 kPa we and others have previously identified in highly fibrotic areas in IPF tissue (Booth et al., 2012).
We next assessed collagen morphology. When visualised by polarised light Picrosirius red microscopy (Figure 5c), highly organised collagen fibrils were evident in vehicle-treated fibrotic control cultures as well as in those treated with IOX2 with no apparent morphological differences (Figure 5—figure supplement 1c). By contrast, ultrastructural analysis of the collagen fibrils using electron microscopy identified a change in collagen nanostructure with a significant decrease in fibril diameter (Figure 5d and e) when pyridinoline cross-linking was increased by IOX2, consistent with our previous observation that fibril diameter is increased by inhibition of pyridinoline cross-linking (Jones et al., 2018). In support of the disease relevance of our in vitro findings, non-hydrated collagen fibrils from patients with IPF have reduced diameters when measured by atomic force microscopy (Figure 5f), consistent with our previous findings that hydrated collagen fibrils extracted from IPF lung tissue have a reduced diameter compared to control samples (Jones et al., 2018). Together, these data identify HIF pathway activation to be a key regulator of pyridinoline cross-link density, collagen fibril nano-architecture, and tissue stiffness.
Pseudohypoxia and loss of FIH activity promotes HIF pathway activation in lung fibroblasts
Whilst canonical HIF pathway activation was observed in lung fibroblasts under hypoxic conditions, elevated levels of HIF1α and HIF2α in IPF fibroblasts under normoxic conditions have recently been reported (Aquino-Gálvez et al., 2019), suggesting a pseudohypoxic state that is a state in which cells express, at least some, hypoxia-associated genes and proteins, regardless of the oxygen status (Russell et al., 2017). To further investigate this possibility, we employed gene set variation analysis (GSVA) using a validated 15-gene HIF/hypoxia gene expression signature (Buffa et al., 2010) to published datasets, identifying that fibroblasts cultured under normoxic conditions from patients with a usual interstitial pneumonia pattern of fibrosis or systemic sclerosis associated lung fibrosis have a significantly increased HIF score (i.e. manifest evidence for HIF upregulation) compared to cultured control fibroblasts (Figure 6a), consistent with an oxygen independent increase in HIF activity. Furthermore, there was a significant increase in the HIF score in lung mesenchymal stromal cells of patients with progressive lung fibrosis compared to those with stable fibrosis (Figure 6b), suggesting that HIF pathway activation may be required for fibrosis progression.
To further investigate the mechanism underlying pseudohypoxic HIF activity in lung fibrosis, we investigated the role of Factor Inhibiting HIF (FIH), a Fe (II)- and 2-oxoglutarate (2-OG)-dependent dioxygenase, which regulates HIF activity and likely the set of HIF target genes upregulated via hydroxylating a conserved asparagine (Asn) residue within the HIFα C-terminal activation domain (CAD), a post-translational modification that blocks interactions between the HIFα-CAD and the histone acetyl transferases CBP/p300 (Elkins et al., 2003; Hewitson et al., 2002; Lando et al., 2002; Mahon et al., 2001; McNeill et al., 2002; Chan et al., 2016). Whilst oxygen tension is the classical regulator of FIH activity, oxidative stress can also inactivate FIH so promoting HIF activity under normoxic conditions (Masson et al., 2012).
Initially, to investigate the potential role of reduced FIH activity in regulating collagen post-translational modifications, we silenced FIH under normoxic conditions; the results show that loss of FIH was sufficient to induce both PLOD2 and LOXL2 expression, and that this effect required HIF promoted transcription, since HIF1β knockdown prevented their induction (Figure 6c). Whilst FIH is stably constitutively expressed across tissues (Bracken et al., 2006; Stolze et al., 2004), the activity levels of FIH can vary (Wang et al., 2018; Tan et al., 2007; Kroeze et al., 2010); thus, we compared FIH activity in control or IPF fibroblasts using a UAS-luc/GAL4DBD-HIF1αCAD binary reporter system (HIF1α CAD reporter) (Coleman et al., 2007). In this assay, the activity of FIH is monitored by a Gal4-driven luciferase reporter that registers the activity of the heterologous Gal4‐HIF‐CAD fusion protein. Inhibition of FIH leads to a reduction in hydroxylation at Asn‐803 of the HIF‐CAD (C-terminal transactivation domain) fusion, which permits increased recruitment of the transcriptional co‐activators p300/CBP and enhanced reporter gene activity (Figure 6d). Consistent with a loss of function of FIH in lung fibrosis, we found FIH activity was significantly reduced in fibroblasts from patients with IPF compared to control fibroblasts (Figure 6e). We further confirmed that a reduction in FIH activity in normal lung fibroblasts could be caused under normoxia by oxidative stress, achieving a level of HIF CAD activity comparable to treatment with the hypoxia mimetic DMOG (Figure 6f). Thus, in lung fibroblasts a reduction in FIH activity may promote HIF pathway activation to dysregulate collagen structure-function.
We next employed the FIH-selective inhibitor DM-NOFD (McDonough et al., 2005) within our 3D model of fibrosis. We confirmed that FIH inhibition by DM-NOFD was sufficient to induce the HIF pathway activation marker gene carbonic anhydrase IX (CA9), PLOD2, and LOXL2 gene expression following 2-week culture (Figure 6—figure supplement 1), and in combination with HIF stabilisation (IOX2) this expression was further increased. Following 6 weeks of culture, DM-NOFD increased mature pyridinoline cross-links (Figure 6g) as well as tissue stiffness (Figure 6h), whilst the combination of DM-NOFD and IOX2 was additive. Thus, FIH inhibition can promote collagen post-translational modification and increase tissue stiffness.
HIF pathway activation localises in areas of active fibrogenesis to cells co-expressing LOXL2 and PLOD2
To support our in vitro studies, we investigated for evidence that HIF regulates PLOD2 and LOXL2 expression within the fibroblast foci of human IPF lung tissue. To assess for HIF activity, we applied GSVA using the 15-gene HIF/hypoxia gene expression signature (Buffa et al., 2010) to the transcriptome of each fibroblast focus, identifying that the HIF signature score, but not TGFβ score, significantly correlated with LOXL2/PLOD2 expression (Figure 7a and b). Furthermore, analysis of serial tissue sections using immunohistochemistry identified that HIF1α and the HIF pathway activation marker gene carbonic anhydrase IX (CA-IX) were expressed within fibroblast foci (Bodempudi et al., 2014; Loncaster et al., 2001), and that this expression localised to cells co-expressing LOXL2 and PLOD2 mRNA (Figure 7c; Figure 7—figure supplement 1). Finally, as FIH is more sensitive to inhibition by oxidative stress (Masson et al., 2012) compared to the PHDs, which are more sensitive to hypoxia than FIH (Masson et al., 2012), we investigated whether HIF activation occurs in lung mesenchymal cells in the context of oxidative stress. We applied GSVA to a published single cell RNAseq dataset (114,396 cells) from 10 control and 20 fibrotic lungs which identified 31 cell types including four fibroblast types (fibroblasts, myofibroblasts, Hyaluronan Synthase 1 (HAS1) high and Perilipin 2 (PLIN2)+ fibroblasts) (Figure 8—figure supplement 1; Habermann et al., 2020). Applying HIF signature or upregulated oxidative stress gene expression signatures to this dataset, we identified that, compared to fibroblasts and myofibroblasts, the HAS1 high and PLIN2+ cells, whose presence was almost exclusively derived from the IPF lung tissue, had significantly increased HIF and upregulated oxidative stress scores (Figure 8a–d) and that these two scores were significantly correlated (Figure 8e), consistent with an increase in pseudohypoxic HIF activity in these disease-specific mesenchymal cell types.
Discussion
We previously reported that altered collagen fibril nanoarchitecture is a core determinant of dysregulated ECM structure-function in human lung fibrosis (Jones et al., 2018). Here, through ex vivo models, bioinformatics and human lung fibrosis tissue studies, we extend these observations leading to the discovery that HIF pathway activation promotes pathologic pyridinlone collagen crosslinking and tissue stiffness by disproportionate induction of collagen-modifying enzymes relative to TGFβ-induced collagen fibril synthesis. Furthermore, this may occur via pseudohypoxic oxygen-independent mechanisms, including the involvement of a decrease in FIH activity that can occur due to oxidative stress, which is thought to play a significant role in IPF pathogenesis (Cheresh et al., 2013). Consistent with this, oxidative stress is increased in subpopulations of IPF fibroblasts whilst FIH activity is significantly reduced in fibroblasts from patients with lung fibrosis resulting in HIF activation under normoxic conditions. Thus, we provide evidence that dysregulated HIF activity is a core regulator of ECM structure-function in human lung fibrosis, and that this may be a key determinant of pathologic tissue stiffness and progressive human lung fibrosis.
TGFβ is a multifunctional growth factor with key roles in normal development and wound healing. It is also considered the prototypic profibrogenic cytokine that promotes increased ECM deposition and has been associated with fibrosis across multiple organs (Yue et al., 2010). We identified that in lung fibroblasts, TGFβ1 increased fibrillar collagen mRNA transcription but its relative effects on PLOD2 or LOXL2 were more limited, suggesting that TGFβ pathway activation alone may be insufficient to cause a substantial increase in pathologic pyridinoline collagen crosslinking. HIF-mediated transcription appears to be relatively more important in inducing PLOD2/LOXL2 relative to interstitial collagen fibril synthesis, so promoting pyridinoline collagen cross-linking, altering collagen fibril nanostructure, and increasing tissue stiffness. While TGFβ has been reported to cause HIF stabilisation (Basu et al., 2011), our findings suggest that this effect is modest and that further HIF-mediated activation is likely required to drive matrix stiffening. This proposal is consistent with a recent result implying a hierarchical relationship in which HIF proteins play a relatively important role in the induction of PLOD2 expression, that is in this regard the effect of the HIF transcription factors appears to be more important relative to that of TGFβ stimulated SMAD proteins (Rosell-García et al., 2019). Thus, we propose that HIF pathway activation acts as a key pathologic ‘second hit’ which disrupts the normal wound healing role of TGFβ by altering collagen fibril nanoarchitecture so dysregulating ECM structure-function and promoting progressive lung fibrosis. In keeping with this concept, GSVA using a validated HIF score (Buffa et al., 2010) applied to microarray data for lung mesenchymal stromal cells showed that HIF activity was increased in cells from patients with progressive lung fibrosis compared with those with stable disease.
We investigated the functional consequences of our findings by employing our long-term 3D in vitro model of lung fibrosis. The results show that HIF pathway activation using a HIF stabilising PHD inhibitor and/or an FIH inhibitor increased pyridinoline cross-links to a level comparable to that identified in IPF tissue, and that the increase in cross-links is associated with an increase in tissue stiffness comparable to the extremes of stiffness identified in IPF tissue together with a reduction in fibril diameter similar to those present in IPF lung tissue. Together these observations support the human disease relevance of HIF pathway activation to IPF and define conditions for future mechanistic studies whereby the 3D in vitro model recapitulates key features of dysregulated collagen structure-function in IPF.
The LOX and LOXL enzymes play key roles in the process of fibrillar collagen production and are tightly regulated in normal development and under physiological conditions (Trackman, 2016). In our LCMD RNA-Seq analyses, LOXL2 was the most highly expressed LOX/LOXL family member as well as the only LOX/LOXL member which correlated with PLOD2 expression, whilst in our previous work investigating collagen structure-function dysregulation in human lung fibrosis, we identified that gene expression of LOXL2 was significantly increased in IPF tissue when compared to age-matched control lung tissue (Jones et al., 2018). Furthermore, using a small molecule LOXL inhibitor in our 3D model of fibrosis, we identified a greater than 50% reduction in mature pyridinoline cross-links using a concentration which completely inhibits LOXL2 but has minimal effects on LOX and LOXL1 (Jones et al., 2018). This is consistent with previous reports that LOXL2 has key pathologic roles in cancer and fibrosis (Barker et al., 2012; Barry-Hamilton et al., 2010). As our studies do not unequivocally exclude a potential role for other LOX/LOXL family members in human lung fibrosis an area of future study could be the systematic silencing of each LOX/LOXL family member using CRISPR gene editing.
The HIF signalling pathway has been reported to be active in lungs and fibroblasts from IPF patients, as determined by the abundance of HIF1α and HIF2α (Aquino-Gálvez et al., 2019; Bodempudi et al., 2014). These findings are consistent with our own observations of increased expression of the HIF-responsive gene, CA-IX. Hypoxia has been proposed to have a pathogenetic role in lung fibrosis through mechanisms including fibroblast proliferation, augmented ER stress, epithelial-mesenchymal transition, and glycolytic reprogramming (Bodempudi et al., 2014; Higgins et al., 2007; Senavirathna et al., 2018; Goodwin et al., 2018). Furthermore, a number of reports have proposed that cross-talk between TGFβ and hypoxia may promote fibrosis, with hypoxia and TGFβ1 synergistically increasing myofibroblast marker expression (Senavirathna et al., 2020), promoting experimental nickel oxide nanoparticle-induced lung fibrosis (Qian et al., 2015), and HIF1α mediating TGF-β-induced PAI-1 production in alveolar macrophages in the bleomycin model of lung fibrosis (Ueno et al., 2011). Here, we extended these previous observations by showing that in lung fibrosis, loss of FIH activity either by siRNA-mediated knockdown or exposure to oxidative stress induces HIF pathway activation independently of oxygen tension, so dysregulating collagen fibrillogenesis under normoxic conditions. FIH negatively regulates HIF activity by hydroxylation of N803, preventing the interaction of the HIFα CAD with CBP/p300 (Elkins et al., 2003; Hewitson et al., 2002; Lando et al., 2002; Mahon et al., 2001; McNeill et al., 2002). Whilst oxygen tension is the classical regulator of FIH activity, oxidative stress can inactivate FIH so promoting HIF activity, with FIH more sensitive to oxidative stress than the HIF prolyl hydroxylases (Masson et al., 2012). Oxidative stress has been implicated as an important profibrotic mechanism in the lungs and other organs (Cheresh et al., 2013; Purnomo et al., 2013; Sánchez-Valle et al., 2012); it can arise from exposure to environmental toxins (e.g. air pollution, tobacco, asbestos, silica, radiation, and drugs such as bleomycin) or from endogenous sources including mitochondria, NADPH oxidase (NOX) activity, and/or inadequate or deficient antioxidant defenses (Cheresh et al., 2013). In our bioinformatic studies, we observed subsets of disease-specific fibroblasts with elevated scores for oxidative stress and these same populations had evidence of HIF pathway activation. Further investigation is merited to understand the consequences of this upon the fibrotic microenvironment including possible dysregulation of epithelial-mesenchymal cross-talk.
To our knowledge whether perturbations in FIH activity could contribute to fibrosis has not been investigated previously. Whilst our studies have focused upon HIF pathways and collagen, functionally FIH, via both HIF-dependent and HIF-independent pathways, has been reported to regulate metabolism (Zhang et al., 2010; Scholz et al., 2016; Peng et al., 2012a; Sim et al., 2018), keratinocyte differentiation (Peng et al., 2012b), vascular endothelial cell survival (Kiriakidis et al., 2015), tumour growth (Pelletier et al., 2012; Kuzmanov et al., 2012) and metastasis (Kang et al., 2018) as well as Wnt signalling (Rodriguez et al., 2016), suggesting that the loss of FIH activity that we have identified could have pleiotropic effects in lung fibrosis, meriting further investigation.
In summary, this study identifies that HIF pathway activation via oxygen dependent and oxygen independent mechanisms promotes pyridinoline collagen cross-linking which is a defining feature of human lung fibrosis that dysregulates ECM structure-function to promote progressive lung fibrosis. Our findings suggest that therapeutically targeting HIF pathway activation might restore ECM homeostasis and so prevent fibrosis progression.
Materials and methods
Lung tissue sampling
Request a detailed protocolHuman lung experiments were approved by the Southampton and South West Hampshire and the Mid and South Buckinghamshire Local Research Ethics Committees (ref 07 /H0607/73), and all subjects gave written informed consent. Clinically indicated IPF lung biopsy tissue samples deemed surplus to clinical diagnostic requirements were formalin fixed and paraffin embedded. All IPF samples were from patients subsequently receiving a multidisciplinary diagnosis of IPF according to international consensus guidelines.
Transcriptomic analysis of in situ IPF fibroblast foci
Request a detailed protocolWe analysed a transcriptomic data set that we have recently established (GSE169500). Briefly, laser capture microdissection was performed upon Formalin-Fixed Paraffin-Embedded (FFPE) control non-fibrotic lung tissue (alveolar septae, [n = 10]) and usual interstitial pneumonia/idiopathic pulmonary fibrosis FFPE lung tissue (fibroblast foci, [n = 10] and adjacent non-affected alveolar septae, [n = 10]). Total RNA was isolated, cDNA libraries were prepared using Ion Ampli‐Seq‐transcriptome human gene expression kit (Life Technologies, Paisley, UK) and sequenced using Ion Torrent Proton Sequencer. A two-stage mapping strategy was used to map the reads to UCSC hg19 human genome. Cufflinks was used to calculate Fragments per Kilobase of exon per Million (FPKM) values.
RNA in-situ hybridisation
Request a detailed protocolSimultaneous in situ detection of the LOXL2 and PLOD2 mRNA on human IPF formalin-fixed paraffin-embedded tissue sections from IPF lung tissue biopsy samples from seven patients were performed using duplex RNAscope technology (Advanced Cell Diagnostics, Biotechne, Abingdon, UK). LOXL2 was detected by C1-probe (Probe-Hs-LOXL2-C1, 311341) and PLOD2 was detected by C2-probe (Probe-Hs-PLOD2-C2, 547761-C2). Briefly, 5 μm human IPF lung tissue sections were baked at 60 °C, deparaffinised in xylene, followed by dehydration in an ethanol series. Target retrieval, hybridisation with target probes, amplification, and chromogenic detection were performed according to the manufacturer’s recommendations (RNAscope 2.5 Duplex Detection protocol for FFPE tissues). Sections were counterstained with Gill’s Hematoxylin, and mounted with Vectamount permanent mounting medium prior to imaging. Assays were performed with duplex positive (PPIB and POLR2A) and negative controls. For co-localisation studies, adjacent serial sections were stained using modified Movat’s pentachrome or hematoxylin and eosin stain as previously reported (Jones et al., 2016). Images were acquired using an Olympus Dotslide Scanner VS110 (Olympus UK, Southend-on-Sea, UK). Semi-quantitative analysis (range absent to +++) of LOXL2 and PLOD2 expression in cell types in IPF tissue was performed by an expert lung pathologist (AF).
2D cell culture, reagents, and transfections
Request a detailed protocolPrimary fibroblast cultures were established from lung parenchyma tissue of patients with IPF obtained by video-assisted thoracoscopic lung biopsy at University Hospital Southampton or non-fibrotic control lung parenchyma tissue (macroscopically normal lung sampled remote from a cancer site in patients undergoing surgery for early stage lung cancer) (Jones et al., 2018; Yao et al., 2019; Conforti et al., 2020; Hill et al., 2019b). MRC5 lung fibroblasts (RRID:CVCL_0440) were obtained from the European Collection of Authenticated Cell Cultures (ECACC). All cultures were tested and free of mycoplasma contamination. Demographic details for the primary lung fibroblast lines are provided in Supplementary file 1b.
Fibroblasts were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 50 units/ml penicillin, 50 μg/ml streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, and 1 x non-essential amino acids (DMEM/FBS) (Life Technologies, Paisley, UK). All cells were kept at 37 °C and 5% CO2. Hypoxic incubation of cells was carried out in a H35 Hypoxystation (Don Whitley Scientific) in which cells were cultured in humidified atmosphere of 1% O2, 5% CO2, and 94% N2 at 37 °C. Following hypoxic incubation, cells were kept in hypoxic condition until samples were collected.
For pro-fibrogenic mediator studies, control lung fibroblasts were treated in the presence of EGF (R&D systems, 236-GMP-200, 10 ng/mL), TGFβ1 (R&D systems, 240-GMP-010, 10 ng/mL), Dimethyloxaloylglycine (DMOG) (Merck, CAS89464-63-1, 1 mM), Wnt3a (R&D systems, 5036-WN-010, 100 ng/mL), Wnt5a (R&D systems, 645-WN-010, 100 ng/mL), or vehicle control (DMSO). For subsequent HIF studies fibroblasts were treated in the presence of DMOG (1 mM), IOX2 (50 μM or 250 μM), or vehicle control (DMSO).
Short interfering RNA (siRNA) oligos against HIF1A (HIF1α) (MU-00401805-01-0002), EPAS1 (HIF2α) (MU-004814-01-0002), ARNT (HIF1β) (MU-007207-01-0002) and HIF1AN (FIH) (MU-004073-02-0002), LOXL2(L-008020-01-0005) were from Dharmacon, Cambridge, UK. Sequences are available from Dharmacon, or Supplementary file 2. As a negative control, we used siGENOME RISC-Free siRNA (Dharmacon, D-001220–01). Human lung fibroblasts were transfected with the indicated siRNA at a final concentration of 35 nM using Lipofectamine RNAiMAX reagent (Invitrogen).
Reporter assay
Request a detailed protocolFIH activity was evaluated using a UAS-luc/GAL4DBD-HIF1αCAD binary reporter system (HIF1α CAD reporter) (Coleman et al., 2007). For the luciferase reporter assays, human lung fibroblasts (control or IPF fibroblasts) were reverse transfected using Lipofectamine 3000 (Invitrogen) with 50 ng of phRL-CMV (Promega UK, Southampton, UK), which constitutively expresses the Renilla luciferase reporter, plus 225 ng of plasmid-GAL4DBD-HIF1αCAD and 225 ng of plasmid-UAS-luc per well. After 24 hour of transfection, a final concentration of 1 mM of DMOG, 1 mM DMSO or 20 μM freshly prepared T‐hydro (tert‐butyl hydroperoxide) (Sigma-Aldrich, Poole, UK) was dosed for 16 hours. T‐hydro was added to the cells every 2 hours. Finally, the transcriptional assay was carried out using the Dual-Luciferase reporter assay system (Promega) following the manufacturer’s protocol.
HIF score, TGFβ score, and oxidative stress GSVA analyses
Request a detailed protocolRaw CEL files for GSE73854 and GSE40839 were downloaded from GEO and imported into RStudio (version 3.6). Raw data were normalised by Robust Multi-array Average (RMA) function in the affy package (version 1.64.0). Multiple probes relating to the same gene were deleted and summarised as the median value for further analysis.
A 15-gene expression signature (ACOT7, ADM, ALDOA, CDKN3, ENO1, LDHA, MIF, MRPS17, NDRG1, P4HA1, PGAM1, SLC2A1, TPI1, TUBB6, and VEGFA) was selected to classify HIF activity (Buffa et al., 2010). All parameters and variables can be found in the accompanying file (Source code 1). This gene signature was defined based on knowledge of gene function and analysis of in vivo co-expression patterns and was highly enriched for HIF-regulated pathways. The HIF score for each sample was calculated by using gene set variation analysis (GSVA) (Hänzelmann et al., 2013) based on this 15-gene expression signature. The TGFβ score for each sample was calculated by using GSVA based on a list of gene from Gene Set: HALLMARK_TGF_BETA_SIGNALING (M5896). All parameters and variables can be found in the accompanying file (Source code 2). The Student t-test was used to evaluate the statistical difference in HIF scores between different conditions.
For single-cell transcriptomic analyses raw CEL files for GSE135893 were downloaded from GEO. Data was processed using the Seurat R package (v3.2.1) in R version 4.0.2. Cell types were assigned based on the published metadata (Habermann et al., 2020). Fibroblast counts data were log-normalised, variable genes quantified and principal component analysis performed on these variable genes. T-stochastic nearest neighbour embedding (t-SNE) dimensional reduction was performed on the top 15 principal components to obtain embeddings for individual cells. GSVA was performed using the 15 genes used for HIF score calculation as above. An oxidative stress score for each cell was calculated using GSVA based on a list of genes upregulated in IPF cell populations (ABCC1, CDKN2D, FES, GCLC, GCLM, GLRX2, HHEX, IPCEF1, JUNB, LAMTOR5, LSP1, MBP, MGST1, MPO, NDUFA6, PFKP, PRDX1, PRDX2, PRDX4, PRNP, SBNO2, SCAF4, SOD1, SOD2, RXN1, TXN, TXNRD1) from Gene Set: HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY (M5938). All parameters and variables can be found in the accompanying file (Source code 3). Upregulated oxidative stress genes were those whose expression was higher in IPF populations than control. Calculated GSVA scores were mapped onto t-SNE plots. Student’s t-test was used to calculate statistical differences between GSVA scores of the different cellular populations.
3D in vitro model of fibrosis
Request a detailed protocolCulture was performed as previously described (Jones et al., 2018). Briefly, peripheral lung fibroblasts were obtained as outgrowths from surgical lung biopsy tissue of patients (n = 3 donors) who were subsequently confirmed with a diagnosis of IPF. All primary cultures were tested and free of mycoplasma contamination. The fibroblasts were seeded in Transwell inserts in DMEM containing 10% FBS. After 24 hr, the media was replaced with DMEM/F12 containing 5% FBS, 10 μg/ml L-ascorbic acid-2-phosphate, 10 ng/ml EGF, and 0.5 μg/ml hydrocortisone with or without 50 μM or 250 μM IOX2 and/or 1 mM DM-NOFD (McDonough et al., 2005), as indicated; each experiment included a vehicle control (0.2% DMSO). TGF-β1 (3 ng/mL) was added to the cultures, and the medium replenished three times per week. After 2 weeks spheroids were lysed for western blotting. After 6 weeks, the spheroids were either snap frozen for parallel-plate compression testing, analysis of cross-linking, and histochemical staining, or fixed using 4% paraformaldehyde for histochemistry or 3% glutaraldehyde in 0.1 M cacodylate buffer at pH 7.4 for electron microscopy.
Reverse transcription quantitative polymerase chain reaction (RTqPCR)
Request a detailed protocolRTqPCR was performed as previously described (Yao et al., 2019; Conforti et al., 2020; Hill et al., 2019b). Primers and TaqMan probe sets were obtained from Primer Design, Southampton, UK (LOXL2, COL1A1, Col3A1, PLOD2), ThermoFisher Scientific, Reading, UK (HIF1A [HIF1α], EPAS1 [HIF2α], ARNT [HIF1β]), and Qiagen, Manchester, UK (QuantiTect Primer Assays, HIF1A, EPAS1, ARNT, LOXL2, PLOD2, CA9, ACTB).
Western blotting
Request a detailed protocolFibroblasts were lysed using 2 x Laemmli SDS sample buffer or urea buffer (8 M Urea, 1 M Thiourea, 0.5% CHAPS, 50 mM DTT, and 24 mM Spermine). Western blotting of cellular lysates was performed for β-actin (1:100.000, Sigma-Aldrich, Poole, UK), LOXL2 (1:1000, R&D Systems, Abingdon, UK), HIF1α (1:1000, BD Biosciences, Wokingham, UK), FIH (1:200, mouse monoclonal 162 C) (Wang et al., 2018), β-tubulin (1:1000, Cell Signaling Technology, London, UK), HIF1 β (1:1000, Cell Signaling Technology), p-Smad2/3 (1:1000, Cell Signaling Technology), p-ERK (1:1000, Cell Signaling Technology), active β-catenin (1:1000, Cell Signaling Technology). Immunodetected proteins were identified using the enhanced chemiluminescence system (Clarity Western Blotting ECL Substrate, Bio-Rad Laboratories Ltd, Watford, UK) or Odyssey imaging system (LI-COR), and evaluated by ImageJ 1.42q software (National Institutes of Health).
Immunofluorescence staining
Request a detailed protocolCells were fixed with 4% paraformaldehyde followed by permeabilisation and staining with primary antibodies for LOXL2 (1:100, R&D Systems), PLOD2 (1:100, Proteintech) and tetramethylrhodamine (TRITC)-conjugated Phalloidin (1:1000, Millipore UK Limited, Watford, UK). The secondary antibodies used were Alexafluor 488 and 647 (1:1000, BioLegend UK Ltd, London, UK). Cell nuclei were counterstained with 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) (1:1000, Millipore UK Limited, Watford, UK). Cells were imaged using an inverted confocal microscope (Leica TCS-SP5 Confocal Microscope, Leica Microsystems).
Immunohistochemistry
Request a detailed protocolControl or IPF lung tissues (n = 3 donors) were fixed and embedded in paraffin wax; tissue sections (4 μm) were processed and stained as previously described (Yao et al., 2019; Hill et al., 2019b). Briefly, the tissue sections were de-waxed, rehydrated and incubated with 3% hydrogen peroxide in methanol for 10 min to block endogenous peroxidase activity. Sections were then blocked with normal goat serum and incubated at room temperature with a primary antibody against CA-IX (1:500, Novus Biologicals, Cambridge, UK) or HIF1α (1:500, Cayman Chemical, Michigan, USA), followed by a biotinylated secondary antibody (1:500, Vector Laboratories Ltd., UK); antibody binding was detected using streptavidin-conjugated horse-radish peroxidase and visualised using DAB before counter-staining with Gill’s Haematoxylin. Images were acquired using an Olympus Dotslide Scanner VS110.
Picrosirius red collagen area quantitation
Request a detailed protocolSample sections, stained with Picrosirius Red as previously described (Jones et al., 2018), were imaged under polarised light and 10 areas were selected at random for each condition (5 each from two donors). Images of dimension 1498 × 1221 pixels with a pixel size of 0.14 μm x 0.14 μm were taken using Olympus Olyvia software and converted through ImageJ to binary RGB images using pre-determined threshold levels (low 25, high 255) to demonstrate areas of collagen fibres only, as previously described (Hadi et al., 2011). The proportion of area composed of collagen fibres within total sample area was then calculated.
Protein, hydroxyproline and collagen cross-link assays performed as previously described (Jones et al., 2018).
Parallel plate compression testing: performed as previously described (Jones et al., 2018).
Transmission electron microscopy: performed as previously described (Jones et al., 2018).
Atomic force microscopy nanoindentation imaging of individual non-hydrated collagen fibrils: performed as previously described (Jones et al., 2018).
Statistics
Statistical analyses were performed in GraphPad Prism v7.02 (GraphPad Software Inc, San Diego, CA) unless otherwise indicated. No data were excluded from the studies and for all experiments, all attempts at replication were successful. For each experiment, sample size reflects the number of independent biological replicates and is provided in the figure legend. Normality of distribution was assessed using the D’Agostino-Pearson normality test. Statistical analyses of single comparisons of two groups utilised Student’s t-test or Mann-Whitney U-test for parametric and non-parametric data respectively. Where appropriate, individual t-test results were corrected for multiple comparisons using the Holm-Sidak method. For multiple comparisons, one-way analysis of variance (ANOVA) with Dunnett’s multiple comparison test or Kruskal-Wallis analysis with Dunn’s multiple comparison test were used for parametric and non-parametric data, respectively. Results were considered significant if p < 0.05, where *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Appendix 1
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files.
-
NCBI Gene Expression OmnibusID GSE135893. Single-cell RNA-sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis.
-
NCBI Gene Expression OmnibusID GSE40839. Expression data from fibroblasts cultured from normal and fibrotic human lung tissue.
-
NCBI Gene Expression OmnibusID GSE73854. Developmental programming in Idiopathic pulmonary fibrosis (IPF).
-
NCBI Gene Expression OmnibusID GSE169500. Spatial transcriptome profiling identifies CREB1 as a regulator of core transcriptional programs in idiopathic pulmonary fibrosis.
References
-
The rationale for targeting the LOX family in cancerNature Reviews. Cancer 12:540–552.https://doi.org/10.1038/nrc3319
-
Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expressionAmerican Journal of Physiology. Renal Physiology 300:F898–F905.https://doi.org/10.1152/ajprenal.00335.2010
-
miR-210 promotes IPF fibroblast proliferation in response to hypoxiaAmerican Journal of Physiology. Lung Cellular and Molecular Physiology 307:L283–L294.https://doi.org/10.1152/ajplung.00069.2014
-
Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigationAmerican Journal of Respiratory and Critical Care Medicine 186:866–876.https://doi.org/10.1164/rccm.201204-0754OC
-
Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environmentThe Journal of Biological Chemistry 281:22575–22585.https://doi.org/10.1074/jbc.M600288200
-
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metageneBritish Journal of Cancer 102:428–435.https://doi.org/10.1038/sj.bjc.6605450
-
Tuning the transcriptional response to hypoxia by inhibiting hypoxia-inducible factor (HIF) prolyl and asparaginyl hydroxylasesThe Journal of Biological Chemistry 291:20661–20673.https://doi.org/10.1074/jbc.M116.749291
-
Oxidative stress and pulmonary fibrosisBiochimica et Biophysica Acta 1832:1028–1040.https://doi.org/10.1016/j.bbadis.2012.11.021
-
Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylasesACS Chemical Biology 8:1488–1496.https://doi.org/10.1021/cb400088q
-
Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factorThe Journal of Biological Chemistry 282:24027–24038.https://doi.org/10.1074/jbc.M704102200
-
Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alphaThe Journal of Biological Chemistry 278:1802–1806.https://doi.org/10.1074/jbc.C200644200
-
Targeting hypoxia-inducible factor-1α/pyruvate dehydrogenase kinase 1 axis by dichloroacetate suppresses bleomycin-induced pulmonary fibrosisAmerican Journal of Respiratory Cell and Molecular Biology 58:216–231.https://doi.org/10.1165/rcmb.2016-0186OC
-
Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural familyThe Journal of Biological Chemistry 277:26351–26355.https://doi.org/10.1074/jbc.C200273200
-
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transitionThe Journal of Clinical Investigation 117:3810–3820.https://doi.org/10.1172/JCI30487
-
Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talkJournal of Lung Health and Diseases 3:31–35.https://doi.org/10.29245/2689-999X/2019/2.1149
-
Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patientsEuropean Journal of Cancer 46:3375–3382.https://doi.org/10.1016/j.ejca.2010.07.018
-
Overexpression of factor inhibiting HIF-1 enhances vessel maturation and tumor growth via platelet-derived growth factor-CInternational Journal of Cancer 131:E603–E613.https://doi.org/10.1002/ijc.27360
-
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervixCancer Research 61:6394–6399.
-
Increased extracellular vesicles mediate WNT5A signaling in idiopathic pulmonary fibrosisAmerican Journal of Respiratory and Critical Care Medicine 198:1527–1538.https://doi.org/10.1164/rccm.201708-1580OC
-
Selective inhibition of factor inhibiting hypoxia-inducible factorJournal of the American Chemical Society 127:7680–7681.https://doi.org/10.1021/ja050841b
-
Oxidative stress and transforming growth factor-β1-induced cardiac fibrosisCardiovascular & Hematological Disorders Drug Targets 13:165–172.https://doi.org/10.2174/1871529x11313020010
-
Cross regulation between hypoxia-inducible transcription factor-1α (HIF-1α) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosisAmerican Journal of Translational Research 7:2364–2378.
-
A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1The Journal of Biological Chemistry 294:14308–14318.https://doi.org/10.1074/jbc.RA119.007674
-
BookChapter 4 - Pseudohypoxia: Life at the EdgeIn: Ujvari B, Roche B, Thomas F, editors. Ecology and Evolution of Cancer. Academic Press. pp. 57–68.
-
Role of oxidative stress and molecular changes in liver fibrosis: a reviewCurrent Medicinal Chemistry 19:4850–4860.https://doi.org/10.2174/092986712803341520
-
Mechanisms of hypoxia signalling: new implications for nephrologyNature Reviews. Nephrology 15:641–659.https://doi.org/10.1038/s41581-019-0182-z
-
Oxygen sensing by HIF hydroxylasesNature Reviews. Molecular Cell Biology 5:343–354.https://doi.org/10.1038/nrm1366
-
Lysyl oxidase isoforms and potential therapeutic opportunities for fibrosis and cancerExpert Opinion on Therapeutic Targets 20:935–945.https://doi.org/10.1517/14728222.2016.1151003
-
Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosisAmerican Journal of Physiology. Lung Cellular and Molecular Physiology 300:L740–L752.https://doi.org/10.1152/ajplung.00146.2010
-
Nuclear entry and export of FIH are mediated by HIF1α and exportin1, respectivelyJournal of Cell Science 131:jcs219782.https://doi.org/10.1242/jcs.219782
-
Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosisThe Journal of Biological Chemistry 297:101096.https://doi.org/10.1016/j.jbc.2021.101096
Article and author information
Author details
Funding
Wellcome Trust (100638/Z/12/Z)
- Mark Jones
Medical Research Council (MR/S025480/1)
- Yihua Wang
Academy of Medical Sciences (SBF002\1038)
- Yihua Wang
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
This project was supported by Medical Research Council (MR/S025480/1), the Wellcome Trust (100638/Z/12/Z), an Academy of Medical Sciences/the Wellcome Trust Springboard Award [SBF002\1,038], and the AAIR Charity. CJB and LSND acknowledge the support of the NIHR Southampton Biomedical Research Centre. LY was supported by China Scholarship Council. YZ was supported by an Institute for Life Sciences PhD Studentship. FC was supported by Medical Research Foundation [MRF-091–0003-RG-CONFO]. ML was supported by a BBSRC Future Leader Fellowship [BB/PO11365/1] and a NIHR Southampton Biomedical Research Centre Senior Research Fellowship. We thank Carine Fixmer, Maria Lane, Benjamin Johnson, and the nurses of the Southampton Biomedical Research Unit for their help in the collection of human samples, supported by the Wessex Clinical Research Network and the National Institute of Health Research, UK. We also thank Dr. Tammie Bishop (University of Oxford) for her technical support in IHC and Prof Sir Peter Ratcliffe (University of Oxford) for the FIH antibody (mouse monoclonal 162 C) and the UAS-luc/GAL4DBD-HIF1αCAD binary reporter system.
Ethics
Human subjects: All human lung experiments were approved by the Southampton and South West Hampshire and the Mid and South Buckinghamshire Local Research Ethics Committees (ref 07/H0607/73), and all subjects gave written informed consent.
Copyright
© 2022, Brereton et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,396
- views
-
- 428
- downloads
-
- 37
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Oxidative stress following a lung injury can alter the structure of collagen, causing it to stiffen and trigger the formation of a fibrotic scar that further hardens the tissue.
-
- Cell Biology
Aggregation of mutant forms of Huntingtin is the underlying feature of neurodegeneration observed in Huntington’s disorder. In addition to neurons, cellular processes in non-neuronal cell types are also shown to be affected. Cells expressing neurodegeneration–associated mutant proteins show altered uptake of ligands, suggestive of impaired endocytosis, in a manner as yet unknown. Using live cell imaging, we show that clathrin-mediated endocytosis (CME) is affected in Drosophila hemocytes and mammalian cells containing Huntingtin aggregates. This is also accompanied by alterations in the organization of the actin cytoskeleton resulting in increased cellular stiffness. Further, we find that Huntingtin aggregates sequester actin and actin-modifying proteins. Overexpression of Hip1 or Arp3 (actin-interacting proteins) could restore CME and cellular stiffness in cells containing Huntingtin aggregates. Neurodegeneration driven by pathogenic Huntingtin was also rescued upon overexpression of either Hip1 or Arp3 in Drosophila. Examination of other pathogenic aggregates revealed that TDP-43 also displayed defective CME, altered actin organization and increased stiffness, similar to pathogenic Huntingtin. Together, our results point to an intimate connection between dysfunctional CME, actin misorganization and increased cellular stiffness caused by alteration in the local intracellular environment by pathogenic aggregates.